TITLE

Vaginal atrophy

PUB. DATE
October 2012
SOURCE
Mayo Clinic Health Letter;Oct2012, Vol. 30 Issue 10, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the management of Vaginal atrophy (atrophic vaginitis) in menopausal women which is thinning and inflammation of vaginal walls and lower urinary tract due to a lack of estrogen. It is suggestive of examining pelvic organs, external genitalia and cervix as well as undergoing urinalysis to diagnose this condition. It also mentions an array of treatment choices and estrogen options, including vaginal estrogen cream, estrogen ring and estrogen tablet.
ACCESSION #
79810726

 

Related Articles

  • Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex. Pickar, James H.; Mirkin, Sebastián // Menopause International;Sep2010, Vol. 16 Issue 3, p121 

    Menopause has been associated with vasomotor symptoms, vulvar-vaginal atrophy and osteoporosis. One of the goals in exploring the potential of selective estrogen receptor modulators (SERMs) was to determine if they could prevent fractures, reduce menopausal symptoms and treat vaginal atrophy,...

  • Progress and Prospects in Treating Postmenopausal Vaginal Atrophy. Winneker, R. C.; Harris, H. A. // Clinical Pharmacology & Therapeutics;Jan2011, Vol. 89 Issue 1, p129 

    The article discusses the modern and potential treatments which can be used to treat postmenopausal vaginal atrophy. It says that dose reduction of vaginally administered estrogens will apparently reduce the risk of side effects. It tackles the unapproved compounds which show positive clinical...

  • Postmenopausal hormones increase risk of urinary incontinence.  // Reactions Weekly;5/8/2004, Issue 1000, p5 

    Discusses research being done on the link between postmenopausal hormone use and urinary incontinence. Reference to a study by F. Grodstein et al published in the February 2004 issue of "Obstetrics and Gynecology" journal; Cases of frequent urinary incontinence; Age-adjusted relative risk of...

  • Vaginal atrophy: Treatment options.  // Mayo Clinic Health Letter;Nov2014, Vol. 32 Issue 11, p7 

    The article focuses on the treatment options for vaginal atrophy including vaginal estrogen and nonhormonal therapies. It offers information on several forms of vaginal estrogen therapy including vaginal estrogen cream, vaginal estrogen ring and ospemifene oral tablet. The nonhormonal therapies...

  • Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy. Chism, Lisa A. // International Journal of Women's Health;2012 Part 2, Vol. 4, p551 

    The purpose of this review is to summarize current information regarding the pathophysiology and management of vaginal atrophy (sometimes called "atrophic vaginitis") and to identify barriers to its treatment with local (or "topical") vaginal estrogen therapy. Relevant clinical trials,...

  • Getting Control Over Urinary Incontinence.  // American Family Physician;8/1/1996, Vol. 54 Issue 2, p683 

    Presents answers to various queries related to urinary incontinence. Overview of causes of urinary incontinence; Information on various kinds of urinary incontinence; Effects of estrogen, a female hormone to control problems related to bladder control; Availability of medicines to control...

  • MORE ABOUT ESTROGEN SKIN PATCHES. SerVaas, Cory // Saturday Evening Post;Jan/Feb87, Vol. 259 Issue 1, p52 

    Discusses the physical and health conditions of menopausal women. Psychological and physical symptoms experienced by menopausal women; Ways by which menopause can affect a woman's professional and personal life; Therapeutic functions of estrogen patch on menopausal women; Steps that can be...

  • Estradiol.  // Reactions Weekly;1/14/2012, Issue 1384, p25 

    The article describes the case of a 43-year-old woman who developed pruritus, an erythematous rash, and indurations after applying a transdermal estradiol patch for estrogen replacement therapy.

  • ...but it doesn't prevent urinary incontinence.  // Modern Medicine;Apr97, Vol. 65 Issue 4, p63 

    Presents an abstract of the article `Efficacy of Estrogen Supplementation in the Treatment of Urinary Incontinence,' by J.A. Fantl, R.C. Bump et al, from the November 1996 issue of an obstetrics and gynecology journal. Ineffectiveness of short-term cyclic hormone replacement therapy for the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics